http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-317077-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-08 |
| filingDate | 1963-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae837a098783f95406f609c0980542c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a417e9bc0e9b85d22c9fa4704330788 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcec7957ba46b25ced05dfc6d66059f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_838f87c56a5b1fd197251ecd1fcaedd6 |
| publicationDate | 1969-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SE-317077-B |
| abstract | The invention comprises isoxazole compounds of the general Formula (I) <FORM:1065889/C2/1> wherein R is a substituted or unsubstituted isocyclic or heterocyclic ring, each of R1 and R11 is a hydrogen atom or an aliphatic hydrocarbon residue, or wherein R1 and R11 together with the nitrogen atom represent a heterocyclic group, A is an alkylene group of 1 to 5 carbon atoms, and wherein one of the groups R and AN< is present at the 3-position and the other at the 5-position, and salts thereof. These compounds may be prepared by reacting a halogenoalkylisoxazole of the Formula (II) <FORM:1065889/C2/2> wherein R and A are as defined above and X is a halogen atom and one of the groups R and AX is in the 3-position and the other in the 5-position, with an amine of the Formula (III) <FORM:1065889/C2/3> wherein R1 and R11 are as defined above, if necessary in the presence of a basic substance. The compounds of Formula (I) or nontoxic salts thereof may be employed in admixture with inert diluents or carriers as antipyretic, analgesic, antitussive, and/or anti-inflammatory agents. |
| priorityDate | 1962-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.